Skip the Needles — Delivering Biologics in Oral Form
October 20, 2024
Vandermosten, John
Three Large-Cap Biotechs That Stand Out in an Uncertain Market
April 06, 2023
Singh, Hartaj
Innovative New Cell and Gene Therapies Show Transformative Benefits
August 18, 2022
Prasad, Raju
Sizing Up Risk Across the Biotech Cap Spectrum
August 18, 2022
Singh, Hartaj
Broad Pullback in Biotech Provides Buying Opportunity for Specific Names
September 30, 2021
Phipps, Matt
AI-Powered ETF Works with IBM Watson to Analyze Market Data
April 05, 2021
Natividad, Chris
Midcap and Small-Cap Biopharma Opportunities a Better Way to Go in 2021
September 30, 2020
Singh, Hartaj
Looking for Tomorrow’s Companies with Opportunities to Outperform
June 26, 2020
Villere III, St. Denis
Looking for the Best Growth Opportunities Globally
May 08, 2020
Gillam, Robert
Data Readouts from CRISPR Trials Will Be Critical in 2019
April 11, 2019
Samy, Manisha
Being More Selective and Focusing on Data in the Gene Therapy Space
April 05, 2019
Amusa, Gbola
A Big Year Ahead for Gene and Cell Therapy Companies
March 22, 2019
Prasad, Raju
Clinical Data and M&A Serve as Catalysts in 2019
March 22, 2019
Roy, Soumit
The First Half of 2019 Expected to Be Rough for the Biotech Sector
March 15, 2019
Singh, Hartaj
CRISPR and NASH Will Be Particularly Interesting and Exciting in 2019
March 15, 2019
Seedhouse, Steven
Building a Portfolio with Multiple Levels of Diversification
January 04, 2019
Cuggino, Michael J.
Focusing on Health Care Through Venture Capital and a Crossover Fund
November 16, 2018
Gadicke, Dr. Ansbert
Buying Growing Small-Cap Companies at Attractive Valuations
November 02, 2018
McDowell, Thomas W., Thome, Cara M.
Clinical Trial Readouts on the Horizon for NASH Monotherapies
October 05, 2018
Seedhouse, Steven
A Favorable Future for Today’s Leaner, More Data-Driven Biotechs
October 02, 2018
Selvaraju, Raghuram
Seeing Growth in Smaller Med Tech Companies
July 13, 2018
Marckx, Brian
Data Consistency is Important When Investing in Gene Therapy
March 21, 2018
Chattopadhyay, Debjit
Gene Editing Companies Have Long-Term Potential to Be M&A Targets
March 16, 2018
Amusa, Gbola
Biotech and Pharma Companies Set For Milestones in 2018
March 08, 2018
Nash, Edward
Good Management Teams and Good Science are Creating Opportunities in Biotech
March 08, 2018
Singh, Hartaj
Weighting Health Care Subsectors According to Trends and Politics
August 29, 2017
Hearle, Michael J.
Looking for Rock-Solid, Dividend-Paying Companies
May 05, 2017
Woodley, Donald F.
Biotech Space on the Cusp of Seismic Changes
April 21, 2017
Chattopadhyay, Debjit
Biotech Space Lining Up for New Product Cycle
April 21, 2017
Singh, Hartaj
A Cautious Perspective on the Biotechnology Sector
March 10, 2017
Shrader, Thomas
Small-to-Midcap Biotech Companies Expected to Regain Levels
March 10, 2017
Vlemmix, Michael
Assessing Each Client’s Unique Needs and Situation
March 10, 2017
Johnston, Todd A.
Building Portfolios with Dividend Growth and Diversification
March 10, 2017
Katz, David A.
Value Investing with a Business-Owner Mentality
February 10, 2017
Heinlein, John
Looking for Change in the Large-Cap Universe
December 30, 2016
Crawford, Kenneth, James, Meghan
Focusing on the Power of Compounding
November 04, 2016
Auxier, J. Jeffrey
Customized Portfolio Management Based on Value and Growth at a Reasonable Price
September 23, 2016
Roberts, Mark
Looking for Clean Balance Sheets and Cash Generation
September 23, 2016
Getsos, Jerry P.
Managing an Income-Based Portfolio with Price-Appreciation Features
September 23, 2016
Montoya, Christopher N.
Expanding the Range of Opportunities with a Multicap Approach
March 28, 2016
Sudyka Jr., Thomas J., Clauser, Chad C.
Emphasizing Caution and Capital Preservation in a Slow Growth Environment
March 11, 2016
Stark, George
High Investor Expectations for the Biotech Sector
January 15, 2016
Nash, Edward
Looking for the World’s Best Companies with the Best Balance Sheets
November 06, 2015
Edgerton, Bobby
Using a Thematic Approach to Growth Investing
October 23, 2015
Kenneth D. Malamed
Opportunities in Regenerative Medicine, Cancer Immunotherapy Markets for Value Investors
July 06, 2015
Stretched Valuations in Biotech Require Cautious Approach
December 15, 2014
Strong Fundamentals in Biotech Justify Even Higher Valuation Levels
December 11, 2014
Managing a Growth Portfolio with a Focus on Company-Specific Metrics
September 08, 2014
Cancer Immunotherapy a Top Focus in Biotechnology Sector
August 20, 2014
Clinical Advancements and Drug Launches in Therapeutics Fuel Investor Enthusiasm
August 19, 2014
Biotech Space Concentrates on Gene Therapy, CAR T-Cell Technology Side
July 23, 2014
Exercising Discipline with a Value Investing Philosophy
July 22, 2014
Biotechnology Capital Inflows Reach Historic Highs
April 07, 2014
Finding Attractive Yields in Financials, IT and Health Care
March 27, 2014
A Balanced Yet Flexible Approach to Investing as the U.S. Economy Improves
February 24, 2014
Investing in Durable Secular Growth Themes
February 14, 2014
Increased Biotech Productivity and Innovation Reflected in FDA-Approved Drugs
August 23, 2013
New Product Generation and an Easing Regulatory Environment in Biopharmaceuticals
August 05, 2013
High Success Rates and Significant M&A in the Antibody Space
April 16, 2013
FDA Approvals Accelerate and Opportunities Arise in Hepatitis C Market
April 08, 2013
Opportunities in Hepatitis C and Genomic Technologies
April 08, 2013
Identifying Hidden Value and Market Opportunities in Biotech Companies
March 21, 2013
Upside Exposure Through Convertibles While Reducing Downside
December 05, 2012
Hepatitis C Therapies Propel Growth in Biotech
August 30, 2012
U.S. Biotech Valuations Appear Attractive Despite Earlier Run
August 17, 2012
Innovation In Cardiovascular And Hepatic Devices And Drugs - Duane Nash - Wedbush Securities
November 21, 2011
Capitalizing On The Secular Increase Of Time Spent Online - Herman Leung - Susquehanna Financial Group Lllp
October 17, 2011
Nano Manufacturing Prospects In Semiconductors - Daniel Heyler - Bank Of America Merrill Lynch (asia Pacific) Ltd.
June 13, 2011
Technology Enablers Monetize Platform Shifts - Kerry Rice - Wedbush Securities
April 04, 2011
Investing In Small- & Midcap Biotech Companies - Dr. Jason Kantor - Rbc Capital Markets
April 04, 2011
Investing In Large-cap, Dividend-growing Companies - Richard E. Helm - Cohen & Steers, Inc.
March 21, 2011
Options Trading & Volatility Management - Richard L. Selvala Jr. - Harvest Volatility Management
December 06, 2010
An Eye On Value & Long-term Growth In Health Services - Dr. Alastair Mackay - Garp Research & Securities
November 15, 2010
Static Or Expanding Hospital Margins Despite Soft Volumes - Frank G. Morgan - Rbc Capital Markets
September 20, 2010
Risk Factors & Overheated Insurance Valuations - Peter Newell - Vontobel Asset Management, Inc.
May 17, 2010
A Close Look At Therapeutics Within Biotech - Matthew L. Kaplan - Ladenburg Thalmann & Co.
April 05, 2010
Investing In Gold & Precious Minerals - Frank E. Holmes - U.s. Global Investors, Inc.
February 08, 2010
Investing In Industrial Products & Services - Alexander J. Roepers - Atlantic Investment Management, Inc.
November 23, 2009
Investing In Commodities & Resources - James J. Puplava - Puplava Financial Services, Inc
November 02, 2009
Exceptional Opportunities In The Current Market - W. Mark Motley - Foster & Motley, Inc.
October 05, 2009
A Modern Approach To Graham & Dodd Investing - Thomas P. Au - R.w. Wentworth & Co., Inc.
October 05, 2009
Outlook For Commercial Airlines - Raymond Neidl - Calyon Securites (usa), Inc.
March 09, 2009
INVESTING IN LARGE & SMALL CAP GROWTH STOCKS - DEGAS A. WRIGHT - DECATUR CAPITAL MANAGEMENT, INC.
January 05, 2009
INVESTING IN LARGE CAP VALUE STOCKS - BRUCE W. KASER - VOYAGEUR ASSET MANAGEMENT INC.
March 10, 2008
SMALL & MICRO-CAP BIOTECHNOLOGY COMPANIES - GEORGE B. ZAVOICO - CANTOR FITZGERALD
February 25, 2008
INVESTING IN LEISURE COMPANIES - STEVEN M. WIECZYNSKI - STIFEL, NICOLAUS & COMPANY, INC.
November 26, 2007
INVESTING IN HIGH QUALITY SMALL CAP COMPANIES - STEVEN R. PURVIS - LUTHER KING CAPITAL MANAGEMENT
July 16, 2007
INVESTING IN MID-CAP STOCKS - DAVID YUCIUS JR. - AURORA INVESTMENT COUNSEL
April 16, 2007
OUTLOOK FOR NATURAL GAS E&P COMPANIES - RICHARD MOORMAN - CAPITAL ONE SOUTHCOAST, INC.
January 15, 2007
CORE GROWTH INVESTING - KEITH C. GODDARD & CHANNING S. SMITH - CAPITAL ADVISORS, INC.
December 11, 2006
DIGITAL MARKETING TECHNOLOGY PROVIDERS - KYLE EVANS - STEPHENS INC.
November 06, 2006
RICHARD ASTER JR. - ASTER INVESTMENT MANAGEMENT
September 04, 2006
ROUNDTABLE FORUM: GAMING
July 10, 2006
ROBIN ROBERTS - FIERY PHOENIX CONSULTING INC
July 10, 2006
ROUNDTABLE FORUM: PRECIOUS METALS
June 26, 2006
Stacey Renner - Ch Energy Group Inc (chg)
May 05, 2006
STEPHEN PATTEN - SECTORAL ASSET MANAGEMENT INC
February 27, 2006
PACKAGED FOODS & AGRIBUSINESS: JOHN MCMILLIN - PRUDENTIAL EQUITY GROUP LLC
February 27, 2006
L.FRIDAY / P.SWANSON - KING INVESTMENT ADVISORS INC
November 14, 2005
AGRIBUSINESS & PACKAGED FOOD COMPANIES: CHRISTINE MCCRACKEN - FTN MIDWEST SECURITIES CORP
November 14, 2005
R.BRIDGES / J.HUBER - GENEVA INVESTMENT MANAGEMENT OF CHICAGO LLC
August 08, 2005
K.CRONK / T.LAPOINTE - COLUMBIA MANAGEMENT GROUP
June 27, 2005
ROUNDTABLE FORUM: BIOTECHNOLOGY
June 27, 2005
LEE DELAPORTE - DREMAN VALUE MANAGEMENT LLC
June 06, 2005
Oscar Spieler - Frontline Ltd (fro)
March 07, 2005
OUTLOOK FOR PAPER & FOREST PRODUCTS: STEVE CHERCOVER - D.A.DAVIDSON & CO
September 20, 2004
SPECIALTY PHARMACEUTICALS & DRUG DELIVERY: LOUIS WEBB - WR HAMBRECHT & CO
September 06, 2004
FREIGHT FORWARDERS & INTEGRATED CARRIERS: MARK DAVIS - FTN MIDWEST RESEARCH SECURITIES CORP
July 12, 2004
BARBARA MARCIN - GABELLI ASSET MANAGEMENT INC
June 07, 2004
DATA STORAGE & SERVICES: DANIEL RENOUARD - ROBERT W. BAIRD & CO
March 08, 2004
NANCY HOLLAND - ABN AMRO ASSET MANAGEMENT (USA) LLC
February 23, 2004
JOHN FRIEDRICHSEN - FIRSTSERVICE CORPORATION (FSRV)
February 23, 2004
J.andrew Richey - Icc Capital Management
October 27, 2003
J.mcalear / D.snee - Columbia Management Group
September 22, 2003
P.morris / S.teach - National Rural Electric Cooperative Association
September 01, 2003
L.holtz / Y.lipsker - Roger Engemann & Associates
July 28, 2003
Small Cap Biotechnology Companies: Russell Gilbertson - Roth Capital Partners Llc
July 28, 2003
Investing In Biotechnology: Mark Monane - Needham & Co
June 02, 2003
Christian Bertelsen - Phoenix Investment Partners / Duff & Phelps
April 28, 2003
Peter Ganucheau Iv - Gsb Investment Management Inc
April 28, 2003
Outlook For Semiconductor Stocks: Danial Scovel - Needham & Co
April 28, 2003
Richard Parry - Tom Johnson Investment Management Inc
April 14, 2003
Michael Mullarkey - Workstream Inc (wstm)
November 25, 2002
U.s. Pharmaceutical Companies: J.riccardo/s.shevick - Bear, Stearns & Co
September 13, 2002
Mark Davidson - Fiduciary Services Corporation
July 08, 2002
Ian Smith - Vertex Pharmaceuticals Inc (vrtx)
June 02, 2002
Catherine Mcleod-seltzer - Pacific Rim Mining (pmu)
May 27, 2002
Gold Stocks: Daniel Mcconvey - Goldman Sachs & Co
May 27, 2002
Alexander Muromcew - Loomis, Sayles & Co
May 06, 2002
Jon Hickman - Jurika & Voyles
April 01, 2002
Merchant Power Companies & Utilities: Thomas Hamlin - Wachovia Securities
October 29, 2001
European Biotechnology Companies: Karl Keegan - Ubs Warburg
October 12, 2001
Anthony Maramarco - David L. Babson & Company
October 01, 2001
Lissa Morgenthaler - Monterey Murphy New World Biotechnology Fund
June 07, 2001
Mary Ann Gray - Federated Kaufmann Fund
June 07, 2001
Mark Frevert - Enron Wholesale Services (ene)
May 31, 2001
Roundtable Forum: Investing In Gold Companies
December 25, 2000
Outlook For Biotechnology Stocks: William Slattery - Deerfield Management
December 18, 2000
Chuck Watson - Dynegy Inc (dyn)
September 20, 2000
John Windeler - Alliance & Leicester Plc (al.l)
September 11, 2000
Todd Chuckry - Request Seismic Surveys Ltd (rsh.to)
August 21, 2000
Allen Ashcroft Jr. - Allied Investment Advisors
June 05, 2000
H. Giles Knight - Ark Funds
February 14, 2000
Emerging Pharamaceutical Companies : Corey Davis - Chase H&q
January 13, 2000
Pharmaceutical Services : Ken Miller - Chase H&q
January 13, 2000
Roundtable Forum: Communications Equipment
January 10, 2000
Roundtable Forum: Major Chemicals
December 20, 1999
David N. Richardson - Asset Management Corporation
November 08, 1999
Wireless Equipment : Brian Modoff - Deutsche Banc Alex. Brown
November 04, 1999
Outlook For Biotechnology : Peter F. Drake - Prudential Securities
November 01, 1999
Anthony M. Marlon - Sierra Health Services Inc (sie)
December 14, 1998
Practice Management: Veterinary & Dental : Anne Reese - Loewenbaum &co
October 05, 1998
Roundtable Forum: Computer Telephony Integration
April 13, 1998
